pmcc logo smlHere are the staff publications for November 2017, compiled 12th December 2017.



Here are the staff publications for November 2017.

Compiled by the Health Sciences Library (RMH, RWH, PMCC and Victorian Mental Health) 12th December 2017.

  1. Akhurst T. Future Directions in PET Imaging of Lung Cancer. PET Clinics 2018;13:83-8.
  2. Akhurst T. Staging of Non-Small-Cell Lung Cancer. PET Clinics 2018;13:1-10.
  3. Ball D. Sixty years ago: The birth of The Journal of Medical Imaging and Radiation Oncology. Journal of Medical Imaging and Radiation Oncology 2017;61:709-10.
  4. Berenjeno IM, Pineiro R, Castillo SD, Pearce W, McGranahan N, Dewhurst SM, Meniel V, Birkbak NJ, Lau E, Sansregret L, Morelli D, Kanu N, Srinivas S, Graupera M, Parker VER, Montgomery KG, Moniz LS, Scudamore CL, Phillips WA, Semple RK, Clarke A, Swanton C, Vanhaesebroeck B. Oncogenic PIK3CA induces centrosome amplification and tolerance to genome doubling. Nature Communications 2017;8:1773.
  5. Blyth CC, Haeusler GM, McMullan BJ, Kotecha RS, Slavin MA, Clark JE. Critical review of current clinical practice guidelines for antifungal therapy in paediatric haematology and oncology. Supportive Care in Cancer 2017;25:3289-90.
  6. Bolshinsky V, Li MH, Ismail H, Burbury K, Riedel B, Heriot A. Multimodal Prehabilitation Programs as a Bundle of Care in Gastrointestinal Cancer Surgery: A Systematic Review. Diseases of the Colon and Rectum 2018;61:124-38.
  7. Brown C, Drosdowsky A, Krishnasamy M. An exploration of medical emergency team intervention at the end of life for people with advanced cancer. European Journal of Oncology Nursing 2017;31:77-83.
  8. Cameron DL, Schroder J, Penington JS, Do H, Molania R, Dobrovic A, Speed TP, Papenfuss AT. GRIDSS: sensitive and specific genomic rearrangement detection using positional de Bruijn graph assembly. Genome Research 2017;27:2050-60.
  9. Campbell JM, Bellman SM, Stephenson MD, Lisy K. Metformin reduces all-cause mortality and diseases of ageing independent of its effect on diabetes control: A systematic review and meta-analysis. Ageing Res Rev 2017;40:31-44.
  10. Carlino MS, Sandhu S. Safety and Efficacy Implications of Discontinuing Combination Ipilimumab and Nivolumab in Advanced Melanoma. Journal of Clinical Oncology 2017;35:3792-3.
  11. Cheng G, Akhurst T. Lung Cancer. PET Clinics 2018;13:xi-xii.
  12. Cheson BD, Heitner Enschede S, Cerri E, Desai M, Potluri J, Lamanna N, Tam C. Tumor Lysis Syndrome in Chronic Lymphocytic Leukemia with Novel Targeted Agents. Oncologist 2017;22:1283-91.
  13. Choy I, Young JM, Badgery-Parker T, Masya LM, Shepherd HL, Koh C, Heriot AG, Solomon MJ. Baseline quality of life predicts pelvic exenteration outcome. ANZ Journal of Surgery 2017;87:935-9.
  14. Chueh AC, Liew MS, Russell PA, Walkiewicz M, Jayachandran A, Starmans MHW, Boutros PC, Wright G, Barnett SA, Mariadason JM, John T. Promoter hypomethylation of NY-ESO-1, association with clinicopathological features and PD-L1 expression in non-small cell lung cancer. Oncotarget 2017;8:74036-48.
  15. Clay TD, Russell PA, Do H, Sundararajan V, Conron M, Wright GM, Dobrovic A, Moore MM, McLachlan SA. Associations between the IASLC/ATS/ERS lung adenocarcinoma classification and EGFR and KRAS mutations. Pathology 2016;48:17-24.
  16. Clay TD, Russell PA, Do H, Sundararajan V, Conron M, Wright GM, Solomon B, Dobrovic A, McLachlan SA, Moore MM. EGFR and KRAS mutations do not enrich for the activation of IL-6, JAK1 or phosphorylated STAT3 in resected lung adenocarcinoma. Medical Oncology 2017;34:175.
  17. Crozier J, Papa N, Perera M, Stewart M, Goad J, Sengupta S, Bolton D, Lawrentschuk N. Lymph node yield in node-negative patients predicts cancer specific survival following radical cystectomy for transitional cell carcinoma. Investigative and Clinical Urology 2017;58:416-22.
  18. de Melo Gagliato D, Cortes J, Curigliano G, Loi S, Denkert C, Perez-Garcia J, Holgado E. Tumor-infiltrating lymphocytes in Breast Cancer and implications for clinical practice. Biochimica Biophysica Acta 2017;1868:527-37.
  19. Denton EJ, Hart D, Russell PA, Wright G, Conron M. Lung cancer and socio-economic status: inextricably linked to place of residence. Internal Medicine Journal 2017;47:563-9.
  20. Douglas A, Lau E, Thursky K, Slavin M. What, where and why: exploring fluorodeoxyglucose-PET's ability to localise and differentiate infection from cancer. Current Opinion in Infectious Diseases 2017;30:552-64.
  21. Duchesne GM, Woo HH. Timing of androgen-deprivation therapy in prostate cancer - Author's reply. Lancet Oncology 2017;18:e635.
  1. Duivenvoorden HM, Rautela J, Edgington-Mitchell LE, Spurling A, Greening DW, Nowell CJ, Molloy TJ, Robbins E, Brockwell NK, Lee CS, Chen M, Holliday A, Selinger CI, Hu M, Britt KL, Stroud DA, Bogyo M, Moller A, Polyak K, Sloane BF, O'Toole SA, Parker BS. Myoepithelial cell-specific expression of stefin A as a suppressor of early breast cancer invasion. Journal of Pathology 2017;243:496-509.
  2. Eakin E, Hayes S, Reeves M, Goode A, Vardy J, Boyle F, Haas M, Hiller J, Mishra G, Jefford M, Koczwara B, Saunders C, Chapman K, Boltong A, Lane K, Baldwin P, Robertson A, Millar L, McKiernan S, Demark-Wahnefried W, Courneya K, Robson E. Translating Research into Community Practice: The Healthy Living after Cancer Partnership Project. Obesity (Silver Spring) 2017;25 Suppl 2:S31.
  3. Estall V, Allen A, Webb A, Bressel M, McCormack C, Spillane J. Outcomes following management of squamous cell carcinoma of the scalp: A retrospective series of 235 patients treated at the Peter MacCallum Cancer Centre. Australasian Journal of Dermatology 2017;58:e207-e15.
  4. Ginn AN, Halliday CL, Douglas AP, Chen SC. PCR-based tests for the early diagnosis of sepsis. Where do we stand? Current Opinion in Infectious Diseases 2017;30:565-72.
  5. Gyorki DE, Barbour A, Hanikeri M, Mar V, Sandhu S, Thompson JF. When is a sentinel node biopsy indicated for patients with primary melanoma? An update of the 'Australian guidelines for the management of cutaneous melanoma'. Australasian Journal of Dermatology 2017;58:274-7.
  6. Hickey M, Trainer A, Braat S, Davey MA, Krejany E, Wark J. What Happens After Menopause? (WHAM): protocol for a prospective, multicentre, age-matched cohort trial of risk-reducing bilateral salpingo-oophorectomy in high-risk premenopausal women. BMJ Open 2017;7:e018758.
  7. Hicks RJ, Murphy DG, Williams SG. Seduction by Sensitivity: Reality, Illusion, or Delusion? The Challenge of Assessing Outcomes after PSMA Imaging Selection of Patients for Treatment. Journal of Nuclear Medicine 2017;58:1969-71.
  8. Hyatt A, Lipson-Smith R, Schofield P, Gough K, Sze M, Aldridge L, Goldstein D, Jefford M, Bell ML, Butow P. Communication challenges experienced by migrants with cancer: A comparison of migrant and English-speaking Australian-born cancer patients. Health Expectations 2017;20:886-95.
  9. Jefford M, Emery J, Grunfeld E, Martin A, Rodger P, Murray AM, De Abreu Lourenco R, Heriot A, Phipps-Nelson J, Guccione L, King D, Lisy K, Tebbutt N, Burgess A, Faragher I, Woods R, Schofield P. SCORE: Shared care of Colorectal cancer survivors: protocol for a randomised controlled trial. Trials 2017;18:506.
  10. Kroon HM, Coventry BJ, Giles MH, Henderson MA, Speakman D, Wall M, Barbour A, Serpell J, Paddle P, Smithers BM, Thompson JF. Safety and Efficacy of Isolated Limb Infusion Chemotherapy for Advanced Locoregional Melanoma in Elderly Patients: An Australian Multicenter Study. Annals of Surgical Oncology 2017;24:3245-51.
  11. Lee YC, Bressel M, Grant P, Russell P, Smith C, Picken S, Camm S, Kiely BE, Milne RL, McLachlan SA, Hickey M, Friedlander ML, Hopper JL, Phillips KA, Kathleen Cuningham Foundation Consortium for Research into Familial Breast C. Improved quality of risk-reducing salpingo-oophorectomy in Australasian women at high risk of pelvic serous cancer. Familial Cancer 2017;16:461-9.
  12. Leong TL, Christie M, Kranz S, Pham K, Hsu A, Irving LB, Asselin-Labat ML, Steinfort DP. Evaluating the Genomic Yield of a Single Endobronchial Ultrasound-guided Transbronchial Needle Aspiration in Lung Cancer: Meeting the Challenge of Doing More With Less. Clinical Lung Cancer 2017;18:e467-e72.
  13. Lisy K, Emery JD, Jefford M. Provider Roles in Survivorship Care: Moving Beyond Surveys of Patient Preference. Journal of Clinical Oncology 2017;35:3890.
  14. Ma Y, Vijande J, Ballester F, Tedgren AC, Granero D, Haworth A, Mourtada F, Fonseca GP, Zourari K, Papagiannis P, Rivard MJ, Siebert FA, Sloboda RS, Smith R, Chamberland MJP, Thomson RM, Verhaegen F, Beaulieu L. A generic TG-186 shielded applicator for commissioning model-based dose calculation algorithms for high-dose-rate (192) Ir brachytherapy. Medical Physics 2017;44:5961-76.
  15. MacManus M, Everitt S. Treatment Planning for Radiation Therapy. PET Clinics 2018;13:43-57.
  16. MacManus M, Everitt S, Schimek-Jasch T, Li XA, Nestle U, Kong FS. Anatomic, functional and molecular imaging in lung cancer precision radiation therapy: treatment response assessment and radiation therapy personalization. Transl Lung Cancer Res 2017;6:670-88.
  17. Masaldan S, Clatworthy SAS, Gamell C, Meggyesy PM, Rigopoulos AT, Haupt S, Haupt Y, Denoyer D, Adlard PA, Bush AI, Cater MA. Iron accumulation in senescent cells is coupled with impaired ferritinophagy and inhibition of ferroptosis. Redox Biol 2018;14:100-15.
  1. Milne RL, Kuchenbaecker KB, Michailidou K, Beesley J, Kar S, Lindstrom S, Hui S, Lemacon A, Soucy P, Dennis J, Jiang X, Rostamianfar A, Finucane H, Bolla MK, McGuffog L, Wang Q, Aalfs CM, Investigators A, Adams M, Adlard J, Agata S, Ahmed S, Ahsan H, Aittomaki K, Al-Ejeh F, Allen J, Ambrosone CB, Amos CI, Andrulis IL, Anton-Culver H, Antonenkova NN, Arndt V, Arnold N, Aronson KJ, Auber B, Auer PL, Ausems M, Azzollini J, Bacot F, Balmana J, Barile M, Barjhoux L, Barkardottir RB, Barrdahl M, Barnes D, Barrowdale D, Baynes C, Beckmann MW, Benitez J, Bermisheva M, Bernstein L, Bignon YJ, Blazer KR, Blok MJ, Blomqvist C, Blot W, Bobolis K, Boeckx B, Bogdanova NV, Bojesen A, Bojesen SE, Bonanni B, Borresen-Dale AL, Bozsik A, Bradbury AR, Brand JS, Brauch H, Brenner H, Bressac-de Paillerets B, Brewer C, Brinton L, Broberg P, Brooks-Wilson A, Brunet J, Bruning T, Burwinkel B, Buys SS, Byun J, Cai Q, Caldes T, Caligo MA, Campbell I, Canzian F, Caron O, Carracedo A, Carter BD, Castelao JE, Castera L, Caux-Moncoutier V, Chan SB, Chang-Claude J, Chanock SJ, Chen X, Cheng TD, Chiquette J, Christiansen H, Claes KBM, Clarke CL, Conner T, Conroy DM, Cook J, Cordina-Duverger E, Cornelissen S, Coupier I, Cox A, Cox DG, Cross SS, Cuk K, Cunningham JM, Czene K, Daly MB, Damiola F, Darabi H, Davidson R, De Leeneer K, Devilee P, Dicks E, Diez O, Ding YC, Ditsch N, Doheny KF, Domchek SM, Dorfling CM, Dork T, Dos-Santos-Silva I, Dubois S, Dugue PA, Dumont M, Dunning AM, Durcan L, Dwek M, Dworniczak B, Eccles D, Eeles R, Ehrencrona H, Eilber U, Ejlertsen B, Ekici AB, Eliassen AH, Embrace, Engel C, Eriksson M, Fachal L, Faivre L, Fasching PA, Faust U, Figueroa J, Flesch-Janys D, Fletcher O, Flyger H, Foulkes WD, Friedman E, Fritschi L, Frost D, Gabrielson M, Gaddam P, Gammon MD, Ganz PA, Gapstur SM, Garber J, Garcia-Barberan V, Garcia-Saenz JA, Gaudet MM, Gauthier-Villars M, Gehrig A, Collaborators GS, Georgoulias V, Gerdes AM, Giles GG, Glendon G, Godwin AK, Goldberg MS, Goldgar DE, Gonzalez-Neira A, Goodfellow P, Greene MH, Alnaes GIG, Grip M, Gronwald J, Grundy A, Gschwantler-Kaulich D, Guenel P, Guo Q, Haeberle L, Hahnen E, Haiman CA, Hakansson N, Hallberg E, Hamann U, Hamel N, Hankinson S, Hansen TVO, Harrington P, Hart SN, Hartikainen JM, Healey CS, Hebon, Hein A, Helbig S, Henderson A, Heyworth J, Hicks B, Hillemanns P, Hodgson S, Hogervorst FB, Hollestelle A, Hooning MJ, Hoover B, Hopper JL, Hu C, Huang G, Hulick PJ, Humphreys K, Hunter DJ, Imyanitov EN, Isaacs C, Iwasaki M, Izatt L, Jakubowska A, James P, Janavicius R, Janni W, Jensen UB, John EM, Johnson N, Jones K, Jones M, Jukkola-Vuorinen A, Kaaks R, Kabisch M, Kaczmarek K, Kang D, Kast K, kConFab AI, Keeman R, Kerin MJ, Kets CM, Keupers M, Khan S, Khusnutdinova E, Kiiski JI, Kim SW, Knight JA, Konstantopoulou I, Kosma VM, Kristensen VN, Kruse TA, Kwong A, Laenkholm AV, Laitman Y, Lalloo F, Lambrechts D, Landsman K, Lasset C, Lazaro C, Le Marchand L, Lecarpentier J, Lee A, Lee E, Lee JW, Lee MH, Lejbkowicz F, Lesueur F, Li J, Lilyquist J, Lincoln A, Lindblom A, Lissowska J, Lo WY, Loibl S, Long J, Loud JT, Lubinski J, Luccarini C, Lush M, MacInnis RJ, Maishman T, Makalic E, Kostovska IM, Malone KE, Manoukian S, Manson JE, Margolin S, Martens JWM, Martinez ME, Matsuo K, Mavroudis D, Mazoyer S, McLean C, Meijers-Heijboer H, Menendez P, Meyer J, Miao H, Miller A, Miller N, Mitchell G, Montagna M, Muir K, Mulligan AM, Mulot C, Nadesan S, Nathanson KL, Collaborators N, Neuhausen SL, Nevanlinna H, Nevelsteen I, Niederacher D, Nielsen SF, Nordestgaard BG, Norman A, Nussbaum RL, Olah E, Olopade OI, Olson JE, Olswold C, Ong KR, Oosterwijk JC, Orr N, Osorio A, Pankratz VS, Papi L, Park-Simon TW, Paulsson-Karlsson Y, Lloyd R, Pedersen IS, Peissel B, Peixoto A, Perez JIA, Peterlongo P, Peto J, Pfeiler G, Phelan CM, Pinchev M, Plaseska-Karanfilska D, Poppe B, Porteous ME, Prentice R, Presneau N, Prokofieva D, Pugh E, Pujana MA, Pylkas K, Rack B, Radice P, Rahman N, Rantala J, Rappaport-Fuerhauser C, Rennert G, Rennert HS, Rhenius V, Rhiem K, Richardson A, Rodriguez GC, Romero A, Romm J, Rookus MA, Rudolph A, Ruediger T, Saloustros E, Sanders J, Sandler DP, Sangrajrang S, Sawyer EJ, Schmidt DF, Schoemaker MJ, Schumacher F, Schurmann P, Schwentner L, Scott C, Scott RJ, Seal S, Senter L, Seynaeve C, Shah M, Sharma P, Shen CY, Sheng X, Shimelis H, Shrubsole MJ, Shu XO, Side LE, Singer CF, Sohn C, Southey MC, Spinelli JJ, Spurdle AB, Stegmaier C, Stoppa-Lyonnet D, Sukiennicki G, Surowy H, Sutter C, Swerdlow A, Szabo CI, Tamimi RM, Tan YY, Taylor JA, Tejada MI, Tengstrom M, Teo SH, Terry MB, Tessier DC, Teule A, Thone K, Thull DL, Tibiletti MG, Tihomirova L, Tischkowitz M, Toland AE, Tollenaar R, Tomlinson I, Tong L, Torres D, Tranchant M, Truong T, Tucker K, Tung N, Tyrer J, Ulmer HU, Vachon C, van Asperen CJ, Van Den Berg D, van den Ouweland AMW, van Rensburg EJ, Varesco L, Varon-Mateeva R, Vega A, Viel A, Vijai J, Vincent D, Vollenweider J, Walker L, Wang Z, Wang-Gohrke S, Wappenschmidt B, Weinberg CR, Weitzel JN, Wendt C, Wesseling J, Whittemore AS, Wijnen JT, Willett W, Winqvist R, Wolk A, Wu AH, Xia L, Yang XR, Yannoukakos D, Zaffaroni D, Zheng W, Zhu B, Ziogas A, Ziv E, Zorn KK, Gago-Dominguez M, Mannermaa A, Olsson H, Teixeira MR, Stone J, Offit K, Ottini L, Park SK, Thomassen M, Hall P, Meindl A, Schmutzler RK, Droit A, Bader GD, Pharoah PDP, Couch FJ, Easton DF, Kraft P, Chenevix-Trench G, Garcia-Closas M, Schmidt MK, Antoniou AC, Simard J. Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer. Nature Genetics 2017;49:1767-78.
  2. Mollah ZUA, Quah HS, Graham KL, Jhala G, Krishnamurthy B, Dharma JFM, Chee J, Trivedi PM, Pappas EG, Mackin L, Chu EPF, Akazawa S, Fynch S, Hodson C, Deans AJ, Trapani JA, Chong MMW, Bird PI, Brodnicki TC, Thomas HE, Kay TWH. Granzyme A Deficiency Breaks Immune Tolerance and Promotes Autoimmune Diabetes Through a Type I Interferon-Dependent Pathway. Diabetes 2017;66:3041-50.
  3. Moreau P, Chanan-Khan A, Roberts AW, Agarwal AB, Facon T, Kumar S, Touzeau C, Punnoose EA, Cordero J, Munasinghe W, Jia J, Salem AH, Freise KJ, Leverson JD, Enschede SH, Ross JA, Maciag PC, Verdugo M, Harrison SJ. Promising efficacy and acceptable safety of venetoclax plus bortezomib and dexamethasone in relapsed/refractory MM. Blood 2017;130:2392-400.
  1. Morton S, Stanworth S, Lozano M, Harrison SJ, Hong FS, Dennington P, McQuilten Z, Worel N, Compernolle V, Kutner JM, Yokoyama APH, Nahirniak S, Germain M, Hume H, Robitaille N, Wilson A, Tinmouth A, Massey E, Boulat C, Woimant G, Tiberghien P, Schulze TJ, Bux J, Pierelli L, Ballester C, Netelenbos T, West KA, Conry-Cantilena C, Eder A, Haley NR, Yazer M, Triulzi D. Vox Sanguinis International Forum on provision of granulocytes for transfusion and their clinical use. Vox Sang 2017;112:e48-e68.
  2. Morton S, Stanworth S, Lozano M, Harrison SJ, Hong FS, Dennington P, McQuilten Z, Worel N, Compernolle V, Kutner JM, Yokoyama APH, Nahirniak S, Germain M, Hume H, Robitaille N, Wilson A, Tinmouth A, Massey E, Boulat C, Woimant G, Tiberghien P, Schulze TJ, Bux J, Pierelli L, Ballester C, Netelenbos T, West KA, Conry-Cantilena C, Eder A, Haley NR, Yazer M, Triulzi D. Vox Sanguinis International Forum on provision of granulocytes for transfusion and their clinical use: summary. Vox Sang 2017;112:680-3.
  3. Musiienko A, Simpson JAD, Murphy D, Thomson B, Heriot A. Low anterior resection adjacent to a pancake kidney: case report. ANZ Journal of Surgery 2017;87:E333-E4.
  4. Nair R, Lamb BW, Geurts N, Alghazo O, Lam W, Lawrentschuk N, Murphy DG. The Role of Local Therapy for Oligometastatic Prostate Cancer: Should We Expect a Cure? Urologic Clinics of North America 2017;44:623-33.
  5. Norris D, Photiou L, Tacey M, Dolianitis C, Varigos G, Foley P, Baker C. Biologics and dermatology life quality index (DLQI) in the Australasian psoriasis population. Journal of Dermatological Treatment 2017;28:731-6.
  6. Oberoi D, White VM, Seymour JF, Miles Prince H, Harrison S, Jefford M, Winship I, Hill D, Bolton D, Kay A, Millar J, Doo NW, Giles G. The influence of unmet supportive care needs on anxiety and depression during cancer treatment and beyond: a longitudinal study of survivors of haematological cancers. Supportive Care in Cancer 2017;25:3447-56.
  7. O'Kane D, Gibson L, du Plessis J, Davidson A, Bolton D, Lawrentschuk N. Delivery of intracavernosal therapies using needle-free injection devices. International Journal of Impotence Research 2017;29:225-8.
  8. Ong WL, Khor R, Bressel M, Tran P, Tedesco J, Tai KH, Ball D, Duchesne G, Foroudi F. Patterns of health services utilization in the last two weeks of life among cancer patients: Experience in an Australian academic cancer center. Asia Pacific Journal of Clinical Oncology 2017;13:400-6.
  9. Osman MM, Iravani A, Hicks RJ, Hofman MS. Detection of Synchronous Primary Malignancies with (68)Ga-Labeled Prostate-Specific Membrane Antigen PET/CT in Patients with Prostate Cancer: Frequency in 764 Patients. Journal of Nuclear Medicine 2017;58:1938-42.
  10. Pal B, Chen Y, Vaillant F, Jamieson P, Gordon L, Rios AC, Wilcox S, Fu N, Liu KH, Jackling FC, Davis MJ, Lindeman GJ, Smyth GK, Visvader JE. Construction of developmental lineage relationships in the mouse mammary gland by single-cell RNA profiling. Nature Communications 2017;8:1627.
  11. Parker C, Snyder R, Jefford M, Dilts D, Wolfe R, Millar J. A Randomized Controlled Trial of an Additional Funding Intervention to Improve Clinical Trial Enrollment. Journal of the National Comprehensive Cancer Network 2017;15:1104-10.
  12. Paterson R, Phillips KA. Genetic testing in women with breast cancer: implications for treatment. Expert Review of Anticancer Therapy 2017;17:991-1002.
  13. Pereira-Salgado A, Westwood JA, Russell L, Ugalde A, Ortlepp B, Seymour JF, Butow P, Cavedon L, Ong K, Aranda S, Breen S, Kirsa S, Dunlevie A, Schofield P. Mobile Health Intervention to Increase Oral Cancer Therapy Adherence in Patients With Chronic Myeloid Leukemia (The REMIND System): Clinical Feasibility and Acceptability Assessment. JMIR Mhealth Uhealth 2017;5:e184.
  14. Pomery A, Schofield P, Xhilaga M, Gough K. Expert agreed standards for the selection and development of cancer support group leaders: an online reactive Delphi study. Supportive Care in Cancer 2018;26:99-108.
  15. Rathi V, Wright G, Constantin D, Chang S, Pham H, Jones K, Palios A, McLachlan SA, Conron M, McKelvie P, Williams R. Clinical validation of the 50 gene AmpliSeq Cancer Panel V2 for use on a next generation sequencing platform using formalin fixed, paraffin embedded and fine needle aspiration tumour specimens. Pathology 2017;49:75-82.
  16. Reilly DJ, Aksakal G, Gilmour RF, Gyorki DE, Chauhan A, Webb A, Henderson MA. Subungual melanoma: Management in the modern era. Journal of Plastic, Reconstructive & Aesthetic Surgery 2017;70:1746-52.
  17. Russell PA, Wright GM. Predominant histologic subtype in lung adenocarcinoma predicts benefit from adjuvant chemotherapy in completely resected patients: discovery of a holy grail? Ann Transl Med 2016;4:16.
  18. Semenec L, Laloo AE, Schulz BL, Vergara IA, Bond PL, Franks AE. Deciphering the electric code of Geobacter sulfurreducens in cocultures with Pseudomonas aeruginosa via SWATH-MS proteomics. Bioelectrochemistry 2018;119:150-60.
  1. Shaw AT, Felip E, Bauer TM, Besse B, Navarro A, Postel-Vinay S, Gainor JF, Johnson M, Dietrich J, James LP, Clancy JS, Chen J, Martini JF, Abbattista A, Solomon BJ. Lorlatinib in non-small-cell lung cancer with ALK or ROS1 rearrangement: an international, multicentre, open-label, single-arm first-in-man phase 1 trial. Lancet Oncology 2017;18:1590-9.
  2. Spicer BA, Conroy PJ, Law RHP, Voskoboinik I, Whisstock JC. Perforin-A key (shaped) weapon in the immunological arsenal. Seminars in Cell & Developmental Biology 2017;72:117-23.
  3. Stirling RG, Russell PA, Wright GM. Defining Measures of Quality in Lung Cancer Diagnosis and Staging. Annals of Thoracic Surgery 2016;101:1628.
  4. Tan L, Solomon B. Genomic Characterization of Lung Cancer and Its Impact on the Use and Timing of PET in Therapeutic Response Assessment. PET Clinics 2018;13:33-42.
  5. Teh BW, Joyce T, Slavin MA, Thursky KA, Worth LJ. Impact of a dedicated post-transplant vaccination service at an Australian cancer centre. Bone Marrow Transplantation 2017;52:1681-3.
  6. Teo ZL, Versaci S, Dushyanthen S, Caramia F, Savas P, Mintoff CP, Zethoven M, Virassamy B, Luen SJ, McArthur GA, Phillips WA, Darcy PK, Loi S. Combined CDK4/6 and PI3Kalpha Inhibition Is Synergistic and Immunogenic in Triple-Negative Breast Cancer. Cancer Research 2017;77:6340-52.
  7. Thang SP, Lung MS, Kong G, Hofman MS, Callahan J, Michael M, Hicks RJ. Peptide receptor radionuclide therapy (PRRT) in European Neuroendocrine Tumour Society (ENETS) grade 3 (G3) neuroendocrine neoplasia (NEN) - a single-institution retrospective analysis. Eur J Nucl Med Mol Imaging 2017.
  8. Udovicich C, Perera M, Hofman MS, Siva S, Del Rio A, Murphy DG, Lawrentschuk N. (68)Ga-prostate-specific membrane antigen-positron emission tomography/computed tomography in advanced prostate cancer: Current state and future trends. Prostate International 2017;5:125-9.
  9. Ventura J, Lobachevsky PN, Palazzolo JS, Forrester H, Haynes NM, Ivashkevich A, Stevenson AW, Hall CJ, Ntargaras A, Kotsaris V, Pollakis GC, Potsi G, Skordylis K, Terzoudi G, Pateras IS, Gorgoulis VG, Georgakilas AG, Sprung CN, Martin OA. Localized Synchrotron Irradiation of Mouse Skin Induces Persistent Systemic Genotoxic and Immune Responses. Cancer Research 2017;77:6389-99.
  10. Venugopal P, Moore S, Lawrence DM, George AJ, Hannan RD, Bray SC, To LB, D'Andrea RJ, Feng J, Tirimacco A, Yeoman AL, Young CC, Fine M, Schreiber AW, Hahn CN, Barnett C, Saxon B, Scott HS. Self-reverting mutations partially correct the blood phenotype in a Diamond Blackfan anemia patient. Haematologica 2017;102:e506-e9.
  11. Wainer Z, Wright GM, Gough K, Daniels MG, Choong P, Conron M, Russell PA, Alam NZ, Ball D, Solomon B. Impact of sex on prognostic host factors in surgical patients with lung cancer. ANZ Journal of Surgery 2017;87:1015-20.
  12. Wang CY, Khoo C, McCormack CJ, Xu W, Pan Y. Acute localised exanthematous pustulosis secondary to pembrolizumab. Australasian Journal of Dermatology 2017;58:322-3.
  13. Wiede F, Tiganis T. PTPN2: a tumor suppressor you want deleted? Immunology and Cell Biology 2017;95:859-61.
  14. Wong A, Williams M, Milne D, Morris K, Lau P, Spruyt O, Fullerton S, McArthur G. Clinical and palliative care outcomes for patients of poor performance status treated with antiprogrammed death-1 monoclonal antibodies for advanced melanoma. Asia Pacific Journal of Clinical Oncology 2017;13:385-90.
  15. Yong MK, Ananda-Rajah M, Cameron PU, Morrissey CO, Spencer A, Ritchie D, Cheng AC, Lewin SR, Slavin M. Cytomegalovirus Reactivation Is Associated with Increased Risk of Late-Onset Invasive Fungal Disease after Allogeneic Hematopoietic Stem Cell Transplantation: A Multicenter Study in the Current Era of Viral Load Monitoring. Biology of Blood and Marrow Transplantation 2017;23:1961-7.
  16. Yong MK, Cameron PU, Slavin MA, Cheng AC, Morrissey CO, Bergin K, Spencer A, Ritchie D, Lewin SR. Low T-Cell Responses to Mitogen Stimulation Predicts Poor Survival in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation. Frontiers in Immunology 2017;8:1506.